Endocrine Abstracts

Introduction: Acromegaly is chronic debilitating disease related with excess GH and insülin-like growth factor 1 (IGF1) secretion. Pegvisomant is a GH receptor antagonist that competes with endogenous GH for its receptor and is often used as a medical therapy in patients with inadequate response to somatostatin analogs.Methods: Forty-six patients are followed with the diagnosis of acromegaly in our clinic. We present the results of six acromegalic p...

Introduction: Primary hyperparathyroidism is associated with cardiovascular disease. In addition, data about cardiovascular abnormalities in patients with asymptomatic primary hyperparathyroidsm (APHPT) is’nt clear. In this study, we aimed to examine the cardiac structure–functions and hs-CRP levels in patients with APHPT.Materials and method: Thirty-one patients with APHPT and 32 sex- and age-matched control cases with similar cardiac risk fac...